Rare diseases
Investigational molecules
Locations
Solnavagen 1 E, S:t Matteus, 113 65 Stockholm, Sweden
Research activity includes studies in major depressive disorder, with a focus on depressive symptoms in people affected by cancer. The sponsor also supports work involving psilocybin for cancer-related depression.
Interest in this area extends to symptom relief and mental health outcomes in patients with serious medical illness.
Region Stockholm – SLSO runs clinical trials in conditions such as Multiple sclerosis, Relapsing multiple sclerosis, Major depression, Type 2 diabetes mellitus, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SwedenSwedenSwedenSwedenSwedenSwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
